融捷健康(300247) - 2020 Q3 - 季度财报

Financial Performance - Operating revenue for the reporting period was CNY 119,054,919.40, down 33.43% year-on-year[7] - Net profit attributable to shareholders was a loss of CNY 22,979,553.36, representing a decline of 328.70% compared to the same period last year[7] - Basic earnings per share were -CNY 0.0286, a decline of 328.80% compared to the same period last year[7] - The weighted average return on net assets was -2.66%, a decrease of 3.29% compared to the previous year[7] - The net loss for Q3 2020 was CNY 18,156,968.32, compared to a net profit of CNY 8,876,137.98 in the same period last year[45] - The net profit for the current period is a loss of CNY 40,700,682.81, compared to a profit of CNY 3,660,631.80 in the previous period[49] - Total comprehensive income for the current period is a loss of CNY 40,700,682.81, compared to a gain of CNY 3,660,631.80 in the previous period[50] - The net loss for the period was CNY 65,857,571.07, significantly higher than the loss of CNY 1,839,189.21 in the same period last year[58] Cash Flow - The net cash flow from operating activities was CNY 4,182,909.76, a decrease of 75.16% year-on-year[7] - Cash flow from operating activities related to sales decreased by 45.44% year-on-year, mainly due to the sale of equity in subsidiaries[20] - Cash received from operating activities totaled CNY 391,394,841.13, down from CNY 746,078,772.46 in the previous period[61] - The net cash flow from financing activities was -33,630,683.34 CNY, an improvement from -117,228,088.65 CNY in the same period last year[62] - The net cash flow from investment activities was 46,409,164.76 CNY, a significant improvement compared to the previous year's negative cash flow of -101,613,385.56 CNY[62] Assets and Liabilities - Total assets at the end of the reporting period were CNY 972,015,037.75, a decrease of 14.32% compared to the end of the previous year[7] - The total liabilities of the company decreased to 105,683,806.32 yuan as of September 30, 2020, down from 244,007,113.84 yuan at the end of 2019, a reduction of about 56.7%[37] - The total current assets increased to CNY 296,096,031.65 from CNY 193,304,790.67 year-over-year[40] - The total liabilities as of September 30, 2020, were CNY 166,194,738.35, compared to CNY 142,188,875.52 in the previous period[41] - The company reported a total equity of CNY 890,520,367.47, with a capital reserve of CNY 1,344,583,497.93[70] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 54,153[11] - The largest shareholder, Rongjie Investment Holding Group Co., Ltd., held 14.54% of the shares[11] Investment and Subsidiaries - The company reported a loss from equity transfer amounting to CNY 1,755,741.53 during the reporting period[8] - The company completed the transfer of 35% equity in its subsidiary Aima Kang to individual Lei Ping, with the transfer process finalized on January 14, 2020[24] - The company approved the transfer of 100% equity in its wholly-owned subsidiary Foresight to Pan Jianzhong, with the transfer completed by March 27, 2020[24] - The company announced a major asset sale on June 8, 2020, intending to sell 100% equity in Shanghai Ruiyu Fitness Products Co., Ltd. for a cash consideration of 18 million yuan, with the transaction approved by the board on July 17, 2020[25] Research and Development - Research and development expenses decreased by 70.56% year-on-year, mainly due to the sale of subsidiaries and reduced R&D spending[19] - The R&D expenses for Q3 2020 were CNY 2,556,533.20, down from CNY 8,287,673.71 in the previous period[44] - Research and development expenses for the current period amount to CNY 924,157.12, down from CNY 1,178,783.61 in the previous period[48] Financial Adjustments and Standards - The company has made adjustments to its accounting policies in accordance with the new revenue standards effective from January 1, 2020[76] - The implementation of the new revenue standard resulted in a decrease of CNY 2,661,115.85 in prepaid expenses and an increase of the same amount in contract assets[77] - Contract liabilities increased by CNY 6,911,643.74 due to the new revenue standard, reflecting a shift from advance receipts[77]